The Cancer Survivors Network (CSN) is a peer support community for cancer patients, survivors, caregivers, families, and friends! CSN is a safe place to connect with others who share your interests and experiences.
Experimental prostate cancer vaccine
Kentr
CSN Member Posts: 111
I just read in Bottom Line Personal (volume 30, number 13, July 1,2009) that there is an experimental vaccine being tested that "...may improve the survival of men with advanced disease."
"If approved by the FDA, Provenge could become an added treatment for late-stage cancer."
This was reported to Bottom Line by Eric J. Small, MD, cancer specialist, University of California, San Francisco, and chief, division of hematology and oncology, UCSF Helen Diller Family Comprehensive Cancer Center.
Kent
"If approved by the FDA, Provenge could become an added treatment for late-stage cancer."
This was reported to Bottom Line by Eric J. Small, MD, cancer specialist, University of California, San Francisco, and chief, division of hematology and oncology, UCSF Helen Diller Family Comprehensive Cancer Center.
Kent
Comments
Discussion Boards
- All Discussion Boards
- 6 Cancer Survivors Network Information
- 6 Welcome to CSN
- 122.5K Cancer specific
- 2.8K Anal Cancer
- 456 Bladder Cancer
- 312 Bone Cancers
- 1.7K Brain Cancer
- 28.6K Breast Cancer
- 408 Childhood Cancers
- 28K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.2K Gynecological Cancers (other than ovarian and uterine)
- 13.1K Head and Neck Cancer
- 6.4K Kidney Cancer
- 681 Leukemia
- 803 Liver Cancer
- 4.2K Lung Cancer
- 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
- 242 Multiple Myeloma
- 7.2K Ovarian Cancer
- 69 Pancreatic Cancer
- 493 Peritoneal Cancer
- 5.6K Prostate Cancer
- 1.2K Rare and Other Cancers
- 544 Sarcoma
- 743 Skin Cancer
- 659 Stomach Cancer
- 192 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.9K Uterine/Endometrial Cancer
- 6.4K Lifestyle Discussion Boards